Insulin Resistance in Pulmonary Arterial Hypertension
Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate 1) the incidence of insulin resistance (a
pre-diabetic state) in patients with pulmonary hypertension, and 2) test the utility of a
validated PH therapy (Tracleer) versus Pioglitazone in the treatment of those patients found
to have insulin resistance.